Pharma-bio Serv Inc (PBSV) financial statements (2021 and earlier)

Company profile

Business Address INDUSTRIAL ZONE STREET 1
DORADO, 00646
State of Incorp.
Fiscal Year End October 31
SIC 8742 - Management Consulting Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2021
TTM
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,98817,13815,49016,07411,77813,79414,927
Cash and cash equivalents18,98817,13815,49016,03011,75213,77414,893
Short-term investments   44272033
Receivables9,56510,97810,0316,9437,2086,8537,448
Other current assets 469454394550981892
Other undisclosed current assets386      
Total current assets:28,93928,58425,97523,41219,53721,62823,267
Noncurrent Assets
Operating lease, right-of-use asset791847 
Property, plant and equipment1992182912982,3912,334854
Long-term investments and receivables   1,250   
Accounts and financing receivable, after allowance for credit loss   1,250   
Other noncurrent assets2702703674184233618
Total noncurrent assets:1,2601,3356581,9672,8132,370872
TOTAL ASSETS:30,19929,91926,63325,37822,35023,99824,139
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,9061,9381,5902,1401,5272,0912,062
Taxes payable2,06239234441224539
Interest and dividends payable1,727 1,725    
Other undisclosed accounts payable and accrued liabilities(1,884)1,546(479)1,7281,5252,0462,023
Debt1,2881,2991114142323
Other undisclosed current liabilities2,3425552,06941224539
Total current liabilities:5,5353,7933,6712,5661,5432,1592,124
Noncurrent Liabilities
Long-term debt and lease obligation5956856746602952
Finance lease, liability 55 
Capital lease obligations6746602952
Operating lease, liability595630 
Liabilities, other than long-term debt 2,0622,2882,503   
Accounts payable and accrued liabilities 2,0622,2702,485   
Other liabilities  1818   
Other undisclosed noncurrent liabilities2,181662     
Total noncurrent liabilities:3,3713,4092,3552,549602952
Total liabilities:8,9077,2026,0265,1151,6032,1882,176
Stockholders' equity
Stockholders' equity attributable to parent21,29322,71720,60820,26420,74721,81021,963
Common stock2222222
Treasury stock, value(394)(394)(393)(305)(248)(233)(187)
Additional paid in capital1,4351,4241,3811,3471,2951,2311,143
Accumulated other comprehensive income (loss)184161144108138(166)(227)
Retained earnings20,06521,52419,47319,11119,56020,97521,232
Total stockholders' equity:21,29322,71720,60820,26420,74721,81021,963
TOTAL LIABILITIES AND EQUITY:30,19929,91926,63325,37822,35023,99824,139

Income statement (P&L) ($ in thousands)

1/31/2021
TTM
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
Revenues21,44021,56419,50717,79715,57919,53723,385
Revenue, net15,57919,53723,385
Cost of revenue(15,044)(14,898)(13,330)(12,111)(11,968)(13,753)(15,900)
Cost of goods and services sold    (11,968)(13,753)(15,900)
Gross profit:6,3966,6676,1775,6873,6115,7837,484
Operating expenses(4,383)(4,441)(4,433)(4,593)(5,036)(5,875)(5,703)
Other undisclosed operating income (loss)(5) 343(2,356)   
Operating income (loss):2,0082,2262,087(1,262)(1,425)(92)1,781
Nonoperating income (expense)216452743614(57)11
Investment income, nonoperating     (55)19
Interest and debt expense      (7)
Income (loss) from continuing operations before equity method investments, income taxes:2,0292,2902,614(826)(1,411)(149)1,785
Other undisclosed income (loss) from continuing operations before income taxes  (391)2,350 (55)7
Income (loss) from continuing operations before income taxes:2,0292,2902,2231,524(1,411)(204)1,793
Income tax expense(237)(239)(136)(2,786)(4)(53)(168)
Income (loss) from continuing operations:1,7922,0512,087(1,262)(1,415)(257)1,625
Income from discontinued operations   2,541   
Net income (loss) available to common stockholders, diluted:1,7922,0512,0871,280(1,415)(257)1,625

Comprehensive Income ($ in thousands)

1/31/2021
TTM
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
Net income (loss):1,7922,0512,0871,280(1,415)(257)1,625
Comprehensive income (loss):1,7922,0512,0871,280(1,415)(257)1,625
Other undisclosed comprehensive income (loss), net of tax, attributable to parent531736(30)30461(91)
Comprehensive income (loss), net of tax, attributable to parent:1,8452,0682,1231,250(1,111)(196)1,534

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: